STOCK TITAN

BlackRock ESG Capital Allocation Term SEC Filings

ECAT NYSE

Welcome to our dedicated page for BlackRock ESG Capital Allocation Term SEC filings (Ticker: ECAT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The SEC filings page for BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT) brings together the fund’s regulatory disclosures as a non-diversified, closed-end management investment company. As a registered investment company, ECAT files documents with the U.S. Securities and Exchange Commission that describe its structure, investment objectives, governance, and material corporate actions.

Regulatory materials referenced in public announcements include tender offer statements on Schedule TO, proxy statements for annual meetings, and related exhibits. Tender offer documents outline the terms under which ECAT has offered to repurchase a portion of its outstanding common shares, including the percentage of shares subject to the offer and the method for determining the purchase price as a percentage of net asset value on a specified date.

Proxy statements and associated filings provide details on proposals submitted to shareholders, such as the election of trustees and a shareholder proposal to terminate BlackRock Advisors, LLC as investment adviser. These filings also form the basis for recommendations issued by proxy advisory firms Institutional Shareholder Services, Glass Lewis, and Egan-Jones, which are discussed in Business Wire releases.

Litigation involving ECAT’s voting bylaws, brought by Saba Capital Management, L.P., is also connected to the fund’s regulatory framework under the Investment Company Act. Court rulings described in public news highlight questions about how ECAT’s voting standards interact with statutory requirements for shareholder elections and board composition.

On Stock Titan, ECAT’s SEC filings are supplemented with AI-powered summaries that explain the key points of lengthy documents in plain language. Real-time updates from the SEC’s EDGAR system allow users to see new filings as they appear, while AI-generated highlights help identify important items in tender offer statements, proxy materials, and other disclosures. This structure enables investors to review ECAT’s regulatory history, advisory arrangements, and governance-related filings more efficiently.

Rhea-AI Summary

Saba Capital Management, L.P., a more than 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a routine share sale. On January 26, 2026, the firm sold 44,054 shares of ECAT common stock at a price of $15.54 per share, coded as a sale transaction.

After this trade, Saba Capital Management, L.P. reported indirect beneficial ownership of 25,660,190 ECAT common shares. The filing lists the ownership form as indirect, without specifying a particular intermediary entity in the ownership description.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported two open‑market sales of common stock. On January 22, 2026, Saba sold 35,831 ECAT shares at $15.50 per share. On January 23, 2026, it sold an additional 58,213 shares at $15.50 per share. After these transactions, Saba reported indirect beneficial ownership of 25,704,244 ECAT common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported selling common shares of the fund in two January transactions. On January 20, 2026, it sold 102,837 common shares at $15.39 per share, leaving 25,968,064 shares beneficially owned on an indirect basis. On January 21, 2026, it sold a further 169,776 common shares at $15.38 per share, after which it beneficially owned 25,798,288 common shares, also reported as indirect ownership.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Saba Capital Management and affiliates report a large position in BlackRock ESG Capital Allocation Term Trust. The Schedule 13D/A (Amendment No. 26) shows that Saba Capital Management, L.P., Saba Capital Management GP, LLC and Boaz R. Weinstein collectively beneficially own 25,798,288 common shares, representing 25.97% of the trust’s outstanding common shares, based on 99,345,793 shares outstanding as of 6/30/25. The filing states that approximately $383,502,360 was paid to acquire these shares, using investor subscription proceeds, related capital appreciation and margin borrowings in the ordinary course of business. The funds and accounts advised by Saba Capital are entitled to dividends and sale proceeds on the shares, and recent trading activity from 11/25/25 to 1/21/26 is listed in an attached schedule.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported two open‑market sales of common stock. On January 15, 2026, it sold 80,452 shares at $15.97 per share. On January 16, 2026, it sold another 75,435 shares at $15.94 per share.

After these transactions, Saba Capital Management, L.P. reported beneficial ownership of 26,146,336 ECAT shares following the first sale and 26,070,901 shares following the second sale, all held indirectly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported selling common shares in two January 2026 transactions. On January 13, 2026, it sold 11,153 shares at a price of $15.92 per share, leaving 26,302,501 shares beneficially owned indirectly after that trade. On January 14, 2026, it sold a further 75,713 shares at $15.89 per share, bringing its indirect beneficial ownership to 26,226,788 ECAT shares following the second transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Saba Capital Management, L.P., a more than 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a sale of common shares. On January 6, 2026, Saba Capital sold 9,943 ECAT common shares at a price of $15.75 per share. After this transaction, Saba Capital beneficially owned 26,313,654 ECAT common shares, reported as held indirectly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a small stock sale. On 01/02/2026, the firm sold 12,660 shares of ECAT common stock in an open-market transaction coded "S" at a price of $15.45 per share. After this transaction, Saba Capital reported beneficial ownership of 26,323,597 shares, held indirectly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

BlackRock ESG Capital Allocation Term Trust insider activity shows a small share sale by a large holder. On 12/24/2025, a reporting person associated with the trust sold 1,100 shares of common stock at a price of $15.57 per share, identified with transaction code "S" for a sale. After this transaction, the reporting person beneficially owned 26,336,257 shares, reported as indirect ownership.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported several recent transactions in the trust’s common shares. On November 28, 2025, Saba sold 9,389 indirect shares at $16.02 each. On the same date, 334,659 indirect shares were reduced at a price of $0, described as a pro-rata distribution in-kind for no consideration. After these moves, its indirectly owned position was 26,391,751 shares. On December 1, 2025, Saba sold an additional 54,394 indirect shares at $16.03, leaving it with 26,337,357 ECAT shares held indirectly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of BlackRock ESG Capital Allocation Term (ECAT)?

The current stock price of BlackRock ESG Capital Allocation Term (ECAT) is $15.53 as of January 27, 2026.

What is the market cap of BlackRock ESG Capital Allocation Term (ECAT)?

The market cap of BlackRock ESG Capital Allocation Term (ECAT) is approximately 1.5B.
BlackRock ESG Capital Allocation Term

NYSE:ECAT

ECAT Rankings

ECAT Stock Data

1.54B
99.35M
0%
43.62%
0.37%
Asset Management
Financial Services
Link
United States
New York

ECAT RSS Feed